NeoGenomics, Inc. (NEO)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$8.97
+4.17%
Mkt Cap $224.11M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 17, 2026 | $188.50M | $190.17M | +0.89% | $0.04 | $0.06 | +50.00% | — | — |
| Q4 2025 Oct 28, 2025 | $188.25M | $187.80M | -0.24% | $0.02 | $0.03 | +50.00% | — | — |
| Q3 2025 Jul 29, 2025 | $183.85M | $181.33M | -1.37% | $0.03 | $0.03 | +0.00% | — | — |
| Q2 2025 Apr 29, 2025 | $182.94M | $168.03M | -8.14% | -$0.02 | -$0.08 | -300.00% | — | — |
| Q1 2025 Feb 18, 2025 | $172.59M | $172.00M | -0.34% | $0.03 | $0.04 | +33.33% | — | — |
| Q4 2024 Nov 5, 2024 | $173.09M | $167.82M | -3.04% | $0.01 | $0.05 | +316.67% | — | — |
| Q3 2024 Jul 29, 2024 | $166.63M | $164.50M | -1.28% | $0.00 | $0.03 | +880.39% | — | — |
| Q2 2024 Apr 30, 2024 | $162.22M | $156.24M | -3.69% | -$0.01 | -$0.02 | -59.24% | — | — |
| Q1 2024 Feb 20, 2024 | $152.53M | $155.55M | +1.98% | $0.01 | $0.03 | +220.51% | — | — |
| Q4 2023 Nov 6, 2023 | $142.00M | $151.95M | +7.01% | -$0.07 | -$0.06 | +14.29% | — | — |
| Q3 2023 Aug 8, 2023 | $137.42M | $146.92M | +6.91% | -$0.10 | -$0.05 | +50.00% | — | — |
| Q2 2023 May 8, 2023 | $126.39M | $137.22M | +8.57% | -$0.14 | -$0.09 | +35.71% | — | — |
| Q1 2023 Feb 23, 2023 | $129.97M | $138.71M | +6.72% | -$0.15 | -$0.06 | +60.00% | — | — |
| Q4 2022 Nov 8, 2022 | $121.54M | $128.78M | +5.96% | -$0.19 | -$0.14 | +26.32% | — | — |
| Q3 2022 Aug 9, 2022 | $122.93M | $125.07M | +1.74% | -$0.22 | -$0.16 | +27.27% | — | — |
| Q2 2022 Apr 27, 2022 | $116.71M | $117.17M | +0.39% | -$0.23 | -$0.20 | +13.04% | — | — |
| Q1 2022 Feb 23, 2022 | $125.74M | $125.73M | -0.01% | -$0.13 | -$0.14 | -7.69% | — | — |
| Q4 2021 Nov 4, 2021 | $126.59M | $121.34M | -4.15% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2021 Aug 6, 2021 | $121.72M | $121.72M | +0.00% | -$0.05 | -$0.01 | +80.00% | — | — |
| Q2 2021 May 5, 2021 | $112.56M | $115.53M | +2.64% | -$0.01 | -$0.04 | -466.57% | — | — |